Opioids and cardioprotection

Pharmacology and Therapeutics

Volumn 89, Issue 2, 2001, Pages 123-137

  Schultz, Jo El J ^a   Gross, Garrett J ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Infarct size; Ischemia; KATP channels; Opioid peptides; Preconditioning; Protein kinase

Indexed keywords

2 METHYL 4A ALPHA (3 HYDROXYPHENYL) 1,2,3,4,4A,5,12,12A ALPHA OCTAHYDROQUINOLINO[2,3,3 G]ISOQUINOLINE; DELTA OPIATE RECEPTOR AGONIST; DELTA1 OPIATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; NALOXONE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANALGESIA; CELL PROTECTION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MORPHINE; MYOCARDIUM; NARCOTICS; OPIOID PEPTIDES; POTASSIUM CHANNELS; PROTECTIVE AGENTS; RABBITS; RATS; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 0035058592     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00106-6     Document Type: Review

References (203)

1. Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: Implications for ischemic preconditioning
2. Endogenous opioids: Biology and function
3. + channel activation reduces loss of opioid dilation after brain injury
4. ca channel activation
5. Evidence for an involvement of the opioid peptidergic system in the reaction to stressful condition
6. κ opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord
7. Autoradiographic localization of opiate receptors in rat brain: Spinal cord and lower medulla
8. Resistance to myocardial ischemia in five rat strains: Is there a genetic component of cardioprotection?
9. Screening for opioids in dog heart
10. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning
11. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium
12. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle
13. Opiate drugs and δ receptor-mediated myocardial protection
14. Effects of κ opioid receptor stimulation in the heart and the involvement of protein kinase C
15. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide
16. The use of hibernation induction triggers for cardiac transplant preservation
17. Use of "natural" hibernation induction trigger for myocardial protection
18. Age-associated increase in rat cardiac opioid production
19. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat
20. Intrinsic cardiac enkephalins inhibit vagal bradycardia in the dog
21. Spinal opioid receptors and adenosine release: Neurochemical and behavioral characterization of opioid subtypes
22. Adenosine release in morphine-induced hypotension in rats
23. + channel
24. Molecular cloning and functional expression of a mu opioid receptor from rat brain
25. Stereospecific blocking effects of maloxone against hemodynamic compromise and ventricular dysfunction due to myocardial ischemia and reperfusion
26. Naloxone blockade of myocardial ischemic preconditioning is stereoselective
27. Naloxone blockade of myocardial ischemic preconditioning does not require central nervous system participation
28. Two-day preservation of major organs with autoperfusion and hibernation induction trigger
29. 5]-enkephalin)
30. Opioid receptor-coupled second messenger systems
31. Met-enkephalin circulates in human plasma
32. Reduced mechanical activity of perfused rat heart following morphine or enkephalin peptides administration
33. Opioid receptor-G protein interactions: Acute and chronic effects of opioids
34. International union of pharmacology XII: Classification of opioid receptors
35. Increased content of immunoreactive Leu-enkephalin and alteration of δ opioid receptor in hearts of spontaneously hypertensive rats
36. Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors
37. Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris
38. Cloning of a delta opioid receptor by functional expression
39. Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia
40. Central and peripheral sites of action for the protective effect of opioids on the rat stomach
41. Protection by opioids against gastric lesions caused by necrotizing agents
42. Intact proenkephalin is the major enkephalin-containing peptide produced in rat adrenal glands after denervation
43. Demonstration by in situ hybridization of the proopiomelanocortin gene in the rat heart
44. The results of exposure to immobilization, hemorrhagic shock, and cardiac hypertrophy on beta-endorphin in rat cardiac tissue
45. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in the rat heart
46. Opioid-induced second window of cardioprotection: Potential role of mitochondrial KATP channels
47. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts
48. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels
49. + channels: Possible mechanism of cardioprotection
50. Systemic methionine-enkephalin evokes cardiostimulatory responses in the human
51. Multiple opioid receptors: Criteria for identification and classification
52. Cardioprotection associated with preconditioning in the anesthetized ferret
53. Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography
54. Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
55. Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents
56. Dynorphin, naloxone and the overflow of norepinephrine overflow during cardiac nerve stimulation in the dog
57. Beta-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland
58. Opioid effects on mitogen-activated protein kinase signaling cascades
59. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system
60. Cardiovascular effects of endogenous opiate systems
61. Isolation and partial characterization of an opioid-like 88kDa hibernation-related protein
62. Proenkephalin mRNA in rat heart
63. Release of beta-endorphin and met-enkephalin during exercise in normal women: Response to training
64. + channel
65. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit
66. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse
67. 6]enkephalin and naltrindole 5-isothiocyanate: Evidence for delta receptor subtypes
68. Opioid mobilize calcium from inositol 1,4,5-triphosphate-sensitive stores in NG108-15 cells
69. Morphine prevents peroxynitrite-induced death of human neuroblastoma SH-SY5Y cells through a direct scavenging action
70. Involvement of endogenous opioids and ATP-sensitive potassium channels in the mediation of carbachol-induced antinociception at the spinal level: A behavioral study in rats
71. Opening of potassium channels: The common cardioprotective link between preconditioning and natural hibernation?
72. The delta opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
73. Roles of opioid receptor and protein kinase C in suppression of reperfusion arrhythmia by preconditioning
74. Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat
75. Opiate binding in rat hearts: Modulation of binding after hemorrhagic shock
76. Evidence for the presence of enkephalins in the heart
77. Pertussis toxin blocks adenosine A1 receptor mediated protection of the ischemic rat heart
78. μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells
79. Enkephalins have a direct positive inotropic effect on cultured cardiac myocytes
80. Consequences of opiate agonist and antagonist in myocardial ischemia suggest a role of endogenous opioid peptides in ischemic heart disease
81. Adrenal medullary enkephalin-like peptides may mediate opioid stress analgesia
82. Marked increases in larger enkephalin-containing polypeptides in the rat adrenal gland following denervation
83. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels
84. The role of endogenous opioids in congestive heart failure: Effects of nalmefene on systemic and regional hemodynamics in dogs
85. Participation of central kappa-opioid receptors in arrhythmogenesis
86. Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis
87. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart
88. Ischemic preconditioning protects against infarction in rat heart
89. Endogenous opioid peptides: Multiple agonists and receptors
90. Association of proenkephalin transcripts with polyribosomes in the heart
91. Anatomical distribution of opioid receptors in mammalians: An overview
92. On the presence of opioid receptors in guinea-pig ventricular tissue
93. Morphine increases myocardial infarction size in rats
94. Pharmacology of opioids
95. Change in opioid peptide level in the heart and blood plasma during acute myocardial ischemia complicated by ventricular fibrillation
96. On the involvement of endogenous μ and δ opiate receptor agonists in the antiarrhythmic effect of adaptation
97. 2]deltorphin II in mice: Evidence for delta receptor subtypes
98. Ischemic preconditioning triggers the activation of MAP kinases and MAPK kinase 2 in rat hearts
99. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: Correlation with receptor distribution
100. Role of endogenous opioid peptides in the acute adaptation to hypoxia
101. Delta-1 opioid receptor dependence of acute hypoxic adaptation
102. Delta-1 opioid agonist acutely increases hypoxic tolerance
103. i2
104. 5]-enkephalin levels in the developing rat heart
105. Opioid gene expression in the developing and adult rat heart
106. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia
107. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits
108. Beta-endorphin response to exercise and mental stress in patients with ischemic heart disease
109. Multiple opiate receptors for multiple opioid peptides
110. Localization of pro-opiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart
111. Cloning and expression of a cDNA for the rat kappa-opioid receptor
112. Delta and kappa selective opioid agonists inhibit adenylyl cyclase activity through activation of Gi proteins in cardiac sarcolemma
113. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
114. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma
115. Opioid receptor types and membrane ion channels
116. Opioid actions on membrane ion channels
117. μ and δ receptors belong to a family of receptors that are coupled to potassium channels
118. An ATP-dependent potassium channel blocker antagonizes morphine analgesia
119. + channel blockers antagonize morphine but not U-50,488H-induced antinociception
120. + channel-acting drugs
121. Further studies on opioids and hibernation: Delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels
122. Extended lung preservation with the use of hibernation trigger factor
123. Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia
124. Prodromal angina limits infarct size: A role for ischemic preconditioning
125. Increase in the relative abundance of preproenkephalin: A messenger RNA in the ventricles of cardiomyopathic hamsters
126. Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarction
127. Classification of opioid receptors
128. Glibenclamide antagonizes the inhibitory effect of morphine on gall bladder emptying
129. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain
130. Neurotransmitter receptor binding in bovine cerebral microvessels
131. Evaluation of opioid peptide gene expression by solution hybridization RNase protection
132. Dissociation of heat shock proteins expression with ischemic tolerance by whole body hyperthermia in rat heart
133. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits
134. Localization of opiate binding sites in kidney and adrenal gland of the rat
135. The "glibenclamide-shift" of centrally-acting antinociceptive agents in mice
136. β-Endorphin acting on the brainstem is involved in the antihypertensive action of clonidine and α-methyldopa in rats
137. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: Role of nitric oxide
138. + channel openers inhibit morphine withdrawal
139. Leucine-enkephalin modulation of catecholamine positive chronotropy in rat atria is receptor-specific and calcium-dependent
140. Cardiopulmonary pharmacology of enkephalins in the conscious dog
141. Enkephalin effects on blood pressure, heart rate, and baroreceptor reflex
142. 125I]β-endorphin to opioid receptors in rat striatal membranes: Biochemical evidence for the existence of a mu/delta opioid receptor complex
143. Ischemic preconditioning reduces infarct size in swine myocardium
144. Evidence for involvement of opioid receptors in ischemic preconditioning in rat heart
145. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart
146. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart
147. Ischemic preconditioning and morphine-induced cardioprotection involve the delta-opioid receptor in the intact rat heart
148. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in the intact rat heart
149. 1 but not μ or κ opioid receptors
150. ATP channels
151. Enkephalin immunoreactive nerve fibers and cell bodies in sympathetic ganglia of the guinea-pig and rat
152. Delta opioid receptors and low temperature myocardial protection
153. + channels
154. Opiate-dependent modulation of adenylate cyclase
155. 5]-enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo
156. 2+ in rat ventricular myocytes
157. i in myocytes
158. The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia
159. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes
160. Protein kinase C: Its role in ischemic preconditioning in the rat
161. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells
162. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes
163. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline
164. 3H]U69593 binding sites in the rat heart by receptor binding assays
165. 5-enkephalin protects isolated adult rabbit cardiomyocytes via δ opioid receptors
166. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: Evidence for G-protein mechanism
167. + channel blocker
168. Effects of naloxone on myocardial ischemic preconditioning in humans
169. δ Opioid receptor subtypes and cross-talk with κ receptors
170. Time window for the contribution of the δ opioid receptor to cardioprotection by ischemic preconditioning in the rat heart
171. Delta and mu receptor agonists correlate with greater depression of cardiac function than morphine sulfate in perfused rat hearts
172. Opioid receptors in rat cardiac sarcolemma: Effect of phenylephrine and isoproterenol
173. Leucine-enkephalin increases the level of inositol (1,4,5) triphosphate and releases calcium from an intracellular pool in rat ventricular cardiac myocytes
174. 2+ release from an intracellular pool in myocytes and neurons
175. Dynorphin gene expression and release in the myocardial cell
176. Phorbol ester regulation of opioid peptide gene expression in myocardial cells: Role of nuclear protein kinase C
177. Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei
178. The regulation of enkephalin levels in adrenomedullary cells and relation to chromaffin vesicle biogenesis and functional plasticity
179. Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction
180. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction
181. Localization of preproenkephalin mRNA in rat heart: Selective gene expression in left ventricular myocardium
182. Antinociception activity of intrathecally administered potassium channel openers and opioid agonists: A common mechanism of action?
183. Diminution of contractile response by κ opioid receptor agonists in isolated rat ventricular cardiomyocytes is mediated via a pertussis toxin-sensitive G protein
184. Dynorphin reduces voltage-dependent calcium conductance of mouse dorsal root ganglion neurons
185. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration
186. Opioid δ receptor subtypes are associated with different potassium channels
187. ATP channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetized pigs
188. Tissue distribution of opioid receptor gene expression in the rat
189. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart - An attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis
190. Opioids in myocardial ischaemia: Potentiating effects of dynorphin on ischaemic arrhythmia, bradycardia and cardiogenic shock following coronary artery occlusion in the rat
191. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte: Involvement of κ-opioid receptor
192. Morphine mimics ischemic preconditioning in human myocardium during PTCA
193. Decreased affinity of κ receptor binding during reperfusion following ischaemic preconditioning in the rat heart
194. Opioid peptide receptor stimulation reverses β adrenergic effects in rat heart cells
195. Opioid peptides in adrenal gland
196. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive potassium channel in mediating the effects of acetylcholine to mimic preconditioning in dogs
197. Cloning and function comparison of kappa and delta opioid receptors from mouse brain
198. A "second window of protection" or delayed preconditioning phenomenon: Future horizons for myocardial protection?
199. Preconditioning protects ischemic rabbit heart by protein kinase C activation
200. Naloxone blocks the cardiac effects of myocardial ischemia and reperfusion in the rat isolated heart
201. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma
202. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats
203. Multiple opiate receptors: Emerging concepts